Minerva Advisors LLC Has $9.68 Million Holdings in InfuSystem Holdings, Inc. $INFU

Minerva Advisors LLC raised its position in shares of InfuSystem Holdings, Inc. (NYSE:INFU) by 5.2% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 1,078,731 shares of the company’s stock after purchasing an additional 52,942 shares during the quarter. InfuSystem accounts for about 6.5% of Minerva Advisors LLC’s investment portfolio, making the stock its 4th biggest holding. Minerva Advisors LLC owned 5.30% of InfuSystem worth $9,676,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. Hillsdale Investment Management Inc. purchased a new stake in shares of InfuSystem during the 3rd quarter valued at about $4,665,000. Teton Advisors LLC purchased a new stake in shares of InfuSystem during the 3rd quarter valued at about $1,917,000. Legato Capital Management LLC boosted its holdings in shares of InfuSystem by 5.5% during the 3rd quarter. Legato Capital Management LLC now owns 86,745 shares of the company’s stock valued at $899,000 after acquiring an additional 4,534 shares during the last quarter. Truffle Hound Capital LLC boosted its holdings in shares of InfuSystem by 27.8% during the 3rd quarter. Truffle Hound Capital LLC now owns 230,000 shares of the company’s stock valued at $2,383,000 after acquiring an additional 50,000 shares during the last quarter. Finally, Essex Investment Management Co. LLC boosted its holdings in shares of InfuSystem by 8.9% during the 3rd quarter. Essex Investment Management Co. LLC now owns 300,397 shares of the company’s stock valued at $3,112,000 after acquiring an additional 24,634 shares during the last quarter. Hedge funds and other institutional investors own 71.13% of the company’s stock.

InfuSystem Stock Performance

Shares of NYSE INFU opened at $9.66 on Tuesday. The firm’s 50-day moving average price is $9.62 and its 200-day moving average price is $9.15. The company has a quick ratio of 1.59, a current ratio of 1.98 and a debt-to-equity ratio of 0.50. The company has a market cap of $194.96 million, a PE ratio of 161.03 and a beta of 1.49. InfuSystem Holdings, Inc. has a 52-week low of $5.08 and a 52-week high of $11.04.

InfuSystem declared that its board has initiated a share repurchase program on Tuesday, May 19th that allows the company to repurchase $20.00 million in outstanding shares. This repurchase authorization allows the company to buy up to 10.3% of its shares through open market purchases. Shares repurchase programs are typically an indication that the company’s management believes its stock is undervalued.

Analyst Upgrades and Downgrades

Separately, Roth Mkm reaffirmed a “buy” rating and set a $15.00 price target (up from $14.00) on shares of InfuSystem in a report on Tuesday, February 24th. Two equities research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $15.00.

Insider Buying and Selling

In other InfuSystem news, CFO Barry G. Steele acquired 7,000 shares of the company’s stock in a transaction that occurred on Friday, May 8th. The shares were bought at an average price of $8.71 per share, with a total value of $60,970.00. Following the completion of the acquisition, the chief financial officer owned 96,590 shares in the company, valued at $841,298.90. This represents a 7.81% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Paul Andrew Gendron acquired 5,000 shares of the company’s stock in a transaction that occurred on Friday, May 8th. The stock was acquired at an average cost of $8.88 per share, for a total transaction of $44,400.00. Following the acquisition, the director owned 70,000 shares of the company’s stock, valued at $621,600. The trade was a 7.69% increase in their position. The disclosure for this purchase is available in the SEC filing. In the last three months, insiders purchased 17,064 shares of company stock worth $150,396. 10.80% of the stock is currently owned by insiders.

About InfuSystem

InfuSystem Holdings Inc is a medical technology company that specializes in the rental, management and servicing of infusion pumps and associated devices used primarily for outpatient infusion therapy. The company provides a comprehensive suite of services that includes equipment delivery, setup and retrieval, preventive and corrective maintenance, reprocessing and quality assurance. InfuSystem’s offerings are designed to help hospitals, ambulatory surgery centers, oncology clinics and private infusion suites streamline clinical operations and maintain compliance with safety standards.

In addition to pump rental and repair services, InfuSystem has expanded into remote patient monitoring solutions.